Home

Medtronic has received the CE mark for a one-month dual antiplatelet therapy (DAPT) indication for high bleeding risk patients implanted with the Resolute Onyx drug-eluting stent. A press release reports that for high bleeding risk patients, this new, first-of-its-kind indication allows physicians to recommend a shorter, one-month regimen of DAPT, following a percutaneous coronary intervention (PCI) with Resolute Onyx.

The press release adds that the approval is the first of its kind globally. Resolute Onyx is available for use in the USA, as well as in Europe and other countries that recognise the CE mark. It is not currently indicated for high bleeding risk patients with one-month DAPT in the USA, but data have been submitted to the US Food and Drug Administration (FDA) with the intent of obtaining a one-month DAPT US indication for Resolute Onyx.

The indication is based on results from the Onyx ONE Global Study, the first prospective, randomised, one-month DAPT trial comparing Resolute Onyx to a competitive drug-eluting stent (BioFreedom drug-coated stent, Biosensors) in nearly 2,000 high bleeding risk patients. In the study, Resolute Onyx met its primary composite endpoint of cardiac death, myocardial infarction or stent thrombosis at one-year showing non-inferiority versus BioFreedom drug-coated stent. Results from the global study were shared during a late-breaking clinical trial session at 2019 Transcatheter Cardiovascular Therapeutics (TCT) conference and were also published in the New England Journal of Medicine.

Azeem Latib (Montefiore Medical Center, New York City, USA) comments: “The use of DAPT for drug-eluting stents is a challenge for high bleeding risk patients who may not be able to safely tolerate the same therapy duration as recommended for the broader patient population. Through the Onyx ONE global clinical programme, we have observed that Resolute Onyx drug-eluting stent with one-month of DAPT in these complex patients is safe and effective. This indication will further substantiate the option for shorter DAPT regimens, if individual patient needs demand it.”

Dave Moeller, vice president and general manager of the Coronary and Renal Denervation business, which is part of the Cardiac and Vascular Group at Medtronic, states: “The growing body of clinical evidence supports the use of Resolute Onyx to meet the needs of complex patient populations. Resolute Onyx has shown exceptional outcomes in complex patient populations and anatomies, including those at a high risk of bleeding, which has helped pave the way for this first-of-its-kind approval.”

The press release states that the Onyx ONE Global Study, together with the Onyx ONE Clear Study—a study that evaluated Resolute Onyx DES in high bleeding risk patients with one-month DAPT in the USA and Japan—make up the robust Medtronic Onyx ONE Month DAPT programme that has enrolled approximately 2,700 patients at up to 130 sites worldwide. To date, more than 22,000 patients have been studied in Medtronic sponsored and funded clinical trials that have addressed DAPT duration.

Source CardiovascularNews

Duc Tin Clinic

Chia sẽ qua facebook bài: Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

Chia sẽ qua google bài: Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

Chia sẽ qua twitter bài: Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

Chia sẽ qua MySpace bài: Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

Chia sẽ qua LinkedIn bài: Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

Chia sẽ qua stumbleupon bài: Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

Chia sẽ qua icio bài: Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

Chia sẽ qua digg bài: Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

Chia sẽ qua yahoo bài: Resolute Onyx becomes first and only drug-eluting stent in Europe to have one-month DAPT indication for high bleeding risk patients

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.